Who really needs a bone scan at time of diagnosis?

Every year tens of thousands of men newly diagnosed with prostate cancer are given a bone scan (and other types of scan) as part of their “normal” diagnostic work-up. The only value of the bone scan is that it is able to identify men who already have (or at least may have evidence suggesting) actual metastatic prostate cancer to their bones at the time of diagnosis. … READ MORE …

PSA velocity: is it really an appropriate indicator for prostate biopsy — or not?

Last Friday we noted that a new paper by Vickers et al. has formally recommended that PSA velocity be removed from guidelines on the use of diagnostic data to decide whether a man should have a biopsy to assess his potential risk for prostate cancer. We expressed no opinion on the article at that time … READ MORE …

ACR and ASTRO issue new guideline on brachytherapy

The American College of Radiology (ACR) and the American Society for Radiation Oncology (ASTRO) have jointly issued a new guidance document on the treatment of prostate cancer with permanent radioactive “seed” implants inserted through the perineum. … READ MORE …

The right way to deliver palliative radiation therapy for pain management

It has come to our attention that the American Society for Radiation Oncology (ASTRO) has developed new guidance on the use of palliative external beam radiation therapy (EBRT) for the management of pain associated with metastasis of cancer to bone — a relatively common problem in late stage, metastatic prostate cancer. … READ MORE …

New European guidelines on clinically localized prostate cancer

The European Association of Urology (EAU) has issued updated guidelines on the screening, diagnosis, and treatment of clinically localized prostate cancer. … READ MORE …

Canadian practice guideline does NOT recommend HIFU

High-intensity focused ultrasound (HIFU) is legally available in Canada as a method for the treatment of prostate cancer. However, a new Canadian practice guideline states that, “HIFU cannot currently be recommended as an alternative to accepted curative treatment approaches for localized prostate cancer.” … READ MORE …

New guidelines on genetic testing and cancer

The American Society for Clinical Oncology has recently updated its guidelines on genetic and genomic testing for susceptibility to cancer. The entire guideline is available on line for any interested reader. … READ MORE …

Clinicians’ opinions on active surveillance and the new NCCN guidelines

Last week we reported on the new NCCN guidance on prostate cancer management, including the heavy emphasis on active surveillance as a first-line treatment option for as many as 40 percent of men newly diagnosed with prostate cancer. Today a new article on Medscape also takes up this issue, with views from a select group of physicians on issues that relate to the implementation of this new guidance.

Better standardization of the physics of brachytherapy

The use of radiation to treat cancer is highly dependent on a detailed appreciation of the physics that underlies the medical application of radioactivity. A new set of guidelines from the American Association for Physicists in Medicine (AAPM) provides technical guidance on prostate brachytherapy procedures … READ MORE …

ACP endorses use of PDE5 inhibitors for ED

The American College of Physicians (ACP) has just issued new guidelines that strongly endorses use of sildenafil (Viagra) and similar drugs for the treatment of erectile dysfunction (ED). … READ MORE …

RTOG issues new guidance for post-surgical EBRT

Michalski et al. have published consensus guidelines from a Radiation Therapy Oncology Group  (RTOG) committee on the  appropriate clinical target volume of the prostate fossa (PF-CTV) for post-surgical, conformal radiation therapy for prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,115 other followers